Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2019 Sep 10;9:12971. doi: 10.1038/s41598-019-49201-1

Mathematical modeling for bioprocess optimization of a protein drug, uricase, production by Aspergillus welwitschiae strain 1–4

Noura El-Ahmady El-Naggar 1,, S A Haroun 2, Eman M El-Weshy 2, E A Metwally 2, A A Sherief 2
PMCID: PMC6736946  PMID: 31506445

Abstract

Microbial uricase is effective protein drug used to treat hyperuricemia and its complications, including chronic gout, also in prophylaxis and treatment of tumor lysis and organ transplants hyperuricemia. Uricase is commonly used as diagnostic reagent in clinical analysis for quantification of uric acid in blood and other biological fluids. Also, it can be used as an additive in formulations of hair coloring agents. A newly isolated strain, Aspergillus sp. 1–4, was able to produce extracellular uricase on a medium containing uric acid as inducer. Phylogenetic analysis based on ITS region sequence analysis and phenotypic characteristics showed that Aspergillus sp. strain 1–4 is closely related to Aspergillus welwitschiae and its nucleotide sequence was deposited in the GenBank database and assigned sequence accession number MG323529. Statistical screening using Plackett-Burman design with 20 runs was applied to screen fifteen factors for their significance on uricase production by Aspergillus welwitschiae. Results of statistical analysis indicated that incubation time has the most significant positive effect on uricase production followed by yeast extract and inoculum size with the highest effect values of 13.48, 5.26 and 4.75; respectively. The interaction effects and optimal levels of these factors were evaluated using central composite design. The maximum uricase production was achieved at incubation time (5 days), yeast extract (2 g/L) and inoculum size (4 mL/50 mL medium) are the optimum levels for maximum uricase production (60.03 U/mL). After optimization, uricase production increased by 3.02-folds as compared with that obtained from the unoptimized medium (19.87 U/mL).

Subject terms: Oxidoreductases, Applied microbiology

Introduction

In all cells of the human body, uric acid is the end product of purine nucleotide metabolism, and is excreted out of the body via the kidneys in the urine. Uric acid normally found in the blood and tissues are derived from both degradation of purine containing foods in normal diets especially red meats and organ meats (such as liver and kidneys), fructose-sweetened drinks, as well as seafood and consumption of alcohol1 and from the breakdown of old cells. Overproduction and accumulation of uric acid crystals in humans blood stream over the normal value (hyperuricemia, due to the absence of human uricase) can promote a painful metabolic disorder disease known as gout2, form kidney stones and subsequent urate nephropathy3 and renal failure4, idiopathic calcium urate nephrolithiasis5. It was also reported that uric acid levels are often elevated in pediatric patients with acute lymphoblastic leukemia6 and toxemia of pregnancy7.

Uricase (urate oxidase, urate: oxygen oxido-reductase, EC 1.7.3.3) is the enzyme which catalyzes the uric acid oxidation to more water-soluble, poorly toxic and rapidly excreted by the kidneys, allantoin, hydrogen peroxide and carbon dioxide8 and plays an important role in nitrogen metabolism.

Uricacid+H2O+O2UricaseAllantoin+H2O2+CO2

The first important uricase application was in the clinical analysis as a diagnostic reagent for uric acid determination in blood and other biological fluids by coupling it with 4-amino-antipyrine-peroxidase system9,10. Uricase is used as a protein drug to reduce the accumulation of toxic urate, in the treatment of hyperuricemia and gout, as well as in prophylaxis and treatment of tumor lysis hyperuricemia11,12. Immobilized uricase can be used as a uric acid biosensor. Administration of uricase was found to be more potent; it reduced the elevated serum urate concentrations more efficiently compared to other urate-lowering therapies like allopurinol13. Rasburicase has been effectively used for the prevention and treatment of hyperuricemia caused by tumor lysis and organ transplants14. It is also used as an additive in commercial formulations of hair coloring agents15.

Microorganisms, higher plants and animals are able to produce uricase on their own, but uricase cannot be produced by humans. Microorganisms have proven to be a very efficient and economical source of uricase because of their economic cultivation, optimization and purification, thus facilitating the microbial production of uricase. Some microorganisms such as Gliocladium viride16, Pseudomonas putida17 and Nocardi farcinica18 have been used to produce uricase. Despite uricase being obtained from several sources, its growing importance in the therapy and diagnosis necessitates the search for new microbial producers to produce uricase with better enzymatic properties and better yield19.

Uricase production by many microorganisms are strongly controlled by medium components and cultural parameters and by their ability to degrade and use uric acid for growth. Optimization of the medium components and culture condition parameters is the main objective of the biological processes where it has a powerful impact on the production of microbial uricase, as it may effect on product concentration, and the cost of downstream product separation20.

The conventional method of optimization is one factor-at-a-time optimization technique, where one factor is optimized by changing it while maintaining the other factors at constant level. The conventional optimization technique has various disadvantages such as high cost, difficulty, time consuming and neglecting the interactions among different variables21. For several decades, well-defined approaches of statistical experimental designs have been effectively used to optimize different nutritional components and environmental conditions to achieve optimal production and to predict response values in relation to the experimental factors22. Response surface methodology (RSM) is an effective technique for optimizing the system of multiple variables, for predicting the optimal conditions with a few experiments, for clarifying the interactive effects of the tested variables on the response, for minimizing the time and costs involved in the study and for avoiding the misinterpretation occurring in one factor at a time optimization23,24.

The objectives of the present work were to determine the potentiality of the newly isolated Aspergillus sp. strain 1–4 for uricase production, to identify the fungal strain and to optimize uricase production by Aspergillus welwitschiae using Plackett–Burman and central composite designs.

Results and Discussion

Potentiality of Aspergillus sp. strain 1–4 for uricase production

The extracellular uricase producing microorganisms convert the suspended insoluble, white crystals of uric acid in the medium used for agar plate assay method to water soluble allantoin, thus producing a clear zone around the colonies. The produced clear zone diameter is directly linked to the extracellular uricase production, meaning a larger clear zone diameter indicated a greater activity of extracellular uricase25. The formation of clear zone around the fungal colony of Aspergillus sp. strain 1–4 indicated its ability to produce uricase. Uricase activity obtained by Aspergillus sp. strain 1–4 under submerged fermentation condition was found to be 19.87 U/mL.

Scanning electron microscopy for Aspergillus sp. strain 1–4

To determine structure and surface fine features of Aspergillus sp. strain 1–4, scanning electron microscope with high resolution was used at different magnifications 200x, 1600x and 1200x). Figure 1 shows the upright conidiophores bearing conidial heads and chains of spherical, rough walled spherical conidia.

Figure 1.

Figure 1

Scanning electron micrographs of Aspergillus sp. strain 1-4; (AC) at different magnifications 200x, 600x and 1200x; respectively.

Molecular identification for Aspergillus sp. strain 1–4

The PCR product of the amplified 18S rRNA fragment with ITS1 and ITS4 primers resulted in approximately 535 bp fragment (Supplementary Fig. S1). The obtained sequence of Aspergillus sp. strain 1–4 was compared with those nucleotide sequences collected from the GeneBank database by using BLAST26. The sequenced product was deposited under accession number MG323529 in the GenBank database. The phylogenetic tree (Fig. 2) was built using neighbor-joining method of Saitou and Nei27, demonstrating the position of Aspergillus sp. strain 1–4 within the genus Aspergillus. Based on the phylogenetic analysis along with the phenotypic characteristics, the Aspergillus sp. strain 1–4 has been identified as Aspergillus welwitschiae strain 1–4.

Figure 2.

Figure 2

Phylogenetic tree obtained by neighbor-joining analysis of 18S ribosomal RNA gene (partial), internal transcribed spacer 1, 5.8S ribosomal RNA gene, internal transcribed spacer 2 and 28S ribosomal RNA gene (partial), showing the position of Aspergillus sp. within the genus Aspergillus. GenBank sequence accession numbers are indicated in parentheses after the strain names.

Screening of the significant variables for uricase production by Aspergillus welwitschiae using Plackett-Burman design

The statistical experimental design of Plackett-Burman (fractional factorial design) is used to identify the most significant independent variables when the researcher encounters a large number of variables and he is not certain that the variables are best for producing maximum response28. The effects of different fifteen factors were studied using the statistical experimental design of Plackett-Burman to identify the most significant variables for optimization process to attain high uricase production. These factors consist of physical factors like (temperature, pH, inoculums size, inoculums age, incubation time and medium volume) and chemicals factors like (sucrose, uric acid, peptone, yeast extract, NaNO3, K2HPO4, NaCl, MgSO4.7H2O and FeSO4.7H2O) as in Table 1. The low (−1) and high (+1) levels selected for the investigated fifteen factors are given in Table 1. The design matrix with the different levels of variables and a set of twenty experiments to determine the production of uricase under different combinations of variables and the corresponding uricase production are given in Table 1. The data in Table 1 show a great variation in the uricase production in the 20 trials of Plackett-Burman design, which range from 20.92 to 58.21 U/mL. This variation is due to the presence of different combinations with the different levels of factors.

Table 1.

Plackett–Burman design at two levels applied to select the factors that significantly affect uricase production by Aspergillus welwitschiae.

Run no. Coded levels of the selected independent variables Uricase activity (U/mL) Residuals
Incubation time Temperature pH Inoculum size Inoculums age Medium volume Sucrose Peptone Uric acid Yeast extract NaNO3 K2HPO4 MgSO4.7H2O NaCl FeSO4. 7H2O D 1 D 2 D 3 D4 Actual Predicted
1 1 1 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 1 1 48.2 49.22 −1.02
2 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 1 1 1 1 −1 −1 1 1 20.92 22.17 −1.25
3 −1 −1 −1 −1 1 −1 1 −1 1 1 1 1 −1 −1 1 1 −1 1 1 46.38 47.40 −1.02
4 1 1 1 1 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 58.21 58.95 −0.74
5 −1 −1 1 −1 1 −1 1 1 1 1 −1 −1 1 1 −1 1 1 −1 −1 31.83 30.58 1.25
6 −1 1 −1 1 −1 1 1 1 1 −1 −1 1 1 −1 1 1 −1 −1 −1 30.01 30.88 −0.87
7 −1 1 1 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 1 1 1 1 −1 30.92 29.54 1.38
8 1 1 1 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 1 58.21 57.47 0.74
9 1 1 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 1 1 1 1 −1 −1 57.29 56.04 1.25
10 1 −1 1 −1 1 1 1 1 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 47.29 48.40 −1.11
11 −1 1 1 1 1 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 1 −1 1 42.74 42.00 0.74
12 1 −1 1 1 1 1 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 1 −1 47.29 48.27 −0.98
13 −1 1 −1 1 1 1 1 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 1 40.01 41.39 −1.38
14 1 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 1 1 1 43.83 42.96 0.87
15 1 1 −1 −1 −1 −1 1 −1 1 −1 1 1 1 1 −1 −1 1 1 −1 44.20 43.05 1.15
16 1 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 1 1 1 1 −1 −1 1 43.65 44.80 −1.15
17 −1 −1 −1 1 −1 1 −1 1 1 1 1 −1 −1 1 1 −1 1 1 −1 46.93 45.78 1.15
18 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 −1 29.1 30.21 −1.11
19 1 −1 −1 −1 −1 1 −1 1 −1 1 1 1 1 −1 −1 1 1 −1 1 40.92 39.94 0.98
20 −1 −1 1 1 −1 1 1 −1 −1 −1 −1 1 −1 1 −1 1 1 1 1 35.47 34.36 1.11
Level Days °C pH  mL/50 mL medium Hour mL g/L g/L g/L g/L g/L g/L g/L g/L g/L
−1 4 25 6 1 48 25 20 0.5 3 0.5 0.5 1 0.2 0.2 0.01
1 7 35 8 4 72 50 30 2 5 2 2 2 0.8 0.8 0.03

“D, dummy”.

In order to determine the relationship between the independent variables and uricase production by Aspergillus welwitschiae, the multiple-regression statistical analysis was performed and the results are presented in Tables 2 and 3. Table 2 and Fig. 3A shows the effect of independent variables on uricase production by Aspergillus welwitschiae using Plackett-Burman design. The large positive or negative effect indicates that the factor has a large impact on uricase production. While the near zero effect means that the factor has little or no effect on uricase production. Among the studied factors: temperature, incubation time, inoculums age, inoculums size, medium volume, uric acid, sucrose, yeast extract, NaNO3, and FeSO4. 7H2O concentrations were found to have positive effects on uricase production. On the other hand, pH, peptone, K2HPO4, MgSO4.7H2O and NaCl concentrations were found to have negative effects on uricase production.

Table 2.

Coefficients, effects and the contributions percentages of the factors affecting production of uricase by Aspergillus welwitschiae using Plackett-Burman design.

Term % Contribution Coefficient Effect
Intercept 42.17
A-Incubation time (days) 46.90 6.74 13.48
B-Temperature (°C) 0.84 0.90 1.80
C-pH 0.28 −0.52 −1.03
D-Inoculum size (mL/50 mL medium) 5.82 2.37 4.75
E-Inoculums age (h) 2.05 1.41 2.82
F-Medium volume (mL/250 mL conical flask) 0.13 0.36 0.71
G-Sucrose (g/L) 1.95 1.37 2.75
H-Peptone (g/L) 1.21 −1.08 −2.16
J-Uric acid (g/L) 3.25 1.77 3.55
K-Yeast extract (g/L) 7.14 2.63 5.26
L-NaNO3 (g/L) 3.95 1.96 3.91
M-K2HPO4 (g/L) 0.87 −0.92 −1.84
N-MgSO4.7H2O (g/L) 23.91 −4.81 −9.62
O-NaCl (g/L) 0.36 −0.59 −1.18
P-FeSO4. 7H2O (g/L) 0.14 0.37 0.75

Table 3.

Regression statistics and ANOVA (analysis of variance) for the Plackett-Burman design experimental results of uricase production by Aspergillus welwitschiae.

Source Sum of squares Df Mean square F-value P-value
Model 1913.177 15 127.545 21.835 0.0044*
A 908.309 1 908.309 155.496 0.0002*
B 16.232 1 16.232 2.779 0.1708
C 5.340 1 5.340 0.914 0.3932
D 112.632 1 112.632 19.282 0.0118*
E 39.677 1 39.677 6.793 0.0597
F 2.519 1 2.519 0.431 0.5472
G 37.763 1 37.763 6.465 0.0638
H 23.410 1 23.410 4.008 0.1159
J 62.906 1 62.906 10.769 0.0305*
K 138.222 1 138.222 23.663 0.0083*
L 76.401 1 76.401 13.079 0.0224*
M 16.895 1 16.895 2.892 0.1642
N 463.088 1 463.088 79.277 0.0009*
O 6.997 1 6.997 1.198 0.3352
P 2.784 1 2.784 0.477 0.5279
Residual 23.365 4 5.841
Std. Dev. 2.416 R-Squared 0.9879
Mean 42.169 Adj R-Squared 0.9427
C.V.% 5.731 Adeq Precision 17.0143
PRESS 584.135

*“Significant values, df: Degree of freedom, P: Level of significance, F: Fishers’s function, C.V: Coefficient of variation”.

Figure 3.

Figure 3

(A) Effect of independent variables on uricase production (The red color represent the independent variables with most significant positive effect on uricase production). (B) Pareto chart illustrates the order and significance of the variables affecting uricase production by Aspergillus welwitschiae using Plackett-Burman design (the blue color represent negative effects and the orange color represent positive effects).

Pareto chart (Fig. 3B) illustrate in descending order the variables influencing the production of uricase by Aspergillus welwitschiae using Plackett-Burman design that placed above and below the horizontal line (t-value limit). A high t-test value and a low probability indicated a high significance29. The standard Pareto chart consists of bars of length that equivalent to the absolute value of the estimated effects divided by the standard error. The bars are shown in accordance with effect value (t-value), with the highest effects at the first. The blue color represents the factors with negative effects (MgSO4.7H2O (N), peptone (H), K2HPO4 (M), NaCl (O) and pH (C)) with values (−9.62, −2.16, −1.84, −1.18 and −1.03; respectively) and the orange color represents the factors with positive effects (incubation time (A), yeast extract (K), inoculum size (D), NaNO3 (L), uric acid (J), inoculums age (E), sucrose concentration (G), temperature (B), FeSO4. 7H2O (P) and medium volume (F)) with coefficient values (13.48, 5.26, 4.75, 3.91, 3.55, 2.82, 2.75, 1.80, 0.75 and 0.71; respectively).

Table 3 shows regression analysis and ANOVA (the analysis of variance) for the Plackett-Burman design experimental results of uricase production by Aspergillus welwitschiae. The model F-value is 21.835, which implies that the model is significant. On the other hand; the P-value used as a tool to verify the significance of each variable; the small P-value indicates a significant effect of the independent variable30. P-values < 0.05 means that the model terms are significant. Variables at confidence levels greater than 95% (P < 0.05) were considered significant31. Some investigators reported that confidence levels higher than 70% are acceptable32. In this case, incubation time (A), MgSO4.7H2O (N), yeast extract (K) and inoculum size (D), NaNO3 (L) and uric acid (J) were most significant factors affecting uricase production with the lower probability values (0.0002, 0.0009, 0.0083, 0.0118, 0.0224 and 0.0305; respectively). Among the most significant factors: incubation time, yeast extract, inoculums size, NaNO3 and uric acid concentrations were found to have positive effects on uricase production. While, MgSO4.7H2O concentration was found to has negative effect on uricase production.

The suitability of the model and the variability of the response explained by the independent variables can be verified with the value of R2 “determination coefficient”. A regression model that has an R2-value larger than 0.9 is considered to have a very high correlation33. The regression model in our study has R2 = 0.9879 which means that 98.79% of variation in uricase production can be explained by the independent variables and only 1.21% of the total changes are not explained by the independent variables. This means that the regression model provides an excellent explanation for the relationship between uricase production and the independent variables. In addition, the Adjusted R2 of 0.9427 is very high to prove the accuracy of the model and is good to calculate uricase production. Also, the adjusted R2 implies a high correlation between the predicted and the observed values. The value of C.V. (5.731%) indicates a large precision of the experiment. The value of PRESS is 584.135 and the values of standard deviation and mean are 2.416 and 42.169; respectively (Table 3).

Regression equation in terms of coded factors:

Response(uricaseactivity,U/mL)=42.17+6.74A+0.9B0.52C+2.37D+1.41E+0.36F+1.37G1.08H+1.77J+2.63K+1.96L0.92M4.81N0.59O+0.37P 1

where A, B, C, D, E, F, G, H, J, K, L, M, N, O and P are “incubation time, temperature, pH, inoculum size, inoculum age, medium volume, sucrose, peptone, uric acid, yeast extract, NaNO3, K2HPO4, MgSO4.7H2O, NaCl and FeSO4.7H2O concentrations”; respectively.

Model adequacy checking

The normal probability plot (NPP) is a tool to indicate if the residuals follow a normal distribution; the data are plotted against a theoretical normal distribution. The normal probability plot of the studentized residuals (Fig. 4A), shows that the plotted points are close to a straight line that indicates the model has been well fitted with the experimental results. A plot of residuals versus the predicted response (Fig. 4B) is a scatter plot of residuals on the y-axis against predicted response values on the x-axis. Figure 4B shows the residuals are randomly scattered around the horizontal zero reference indicating a good fit of the model for uricase production by Aspergillus welwitschiae. The relationship between predicted and actual (experimental) values of uricase production by Aspergillus welwitschiae is presented in Fig. 4C that indicates the model is sufficient to illustrate uricase activity by Aspergillus welwitschiae.

Figure 4.

Figure 4

(A) The normal probability plot of the studentized residuals. (B) Plot of residuals against predicted values. (C) Plot of predicted vs. actual values for uricase production by Aspergillus welwitschiae determined by the first-order polynomial equation.

In a confirmation experiment, the medium of the following composition g/L: sucrose 30, peptone 0.5, uric acid 5, NaNO3 0.5, yeast extract 2, MgSO4.7H2O 0.2, K2HPO4 1, NaCl 0.2 and FeSO4.7H2O 0.03, medium volume 50 mL/250 mL flask, inoculum size 1% (v/v), incubation time 7 days, inoculum age 48 h, incubation temperature 35 °C and pH 8 was used. Under the previously mentioned medium composition and physical conditions, the obtained experimental uricase activity was 58.21 U/mL which is greater than uricase activity obtained using the basal medium prior to applying Plackett-Burman design by 2.92 times (19.87 U/mL). The experimental uricase activity (58.21 U/mL) was close to the predicted value of 57.47 U/mL. This revealed a high degree of precision (98.72%); its percentage error is 1.28%.

Optimization of significant variables affecting uricase production by Aspergillus welwitschiae using central composite design (CCD)

The most significant variables positively affect uricase production as identified by Plackett–Burman design results (incubation time, inoculum size and yeast extract with contribution percentages of 46.90, 5.82, and 7.14%; respectively) were further subjected to the central composite design to identify possible interactions between these factors and to determine optimal levels of these variables to produce maximum uricase production by Aspergillus welwitschiae.

Table 4 shows central composite design matrix that present the uricase production by Aspergillus welwitschiae in the 20 experiments of the design as influenced by incubation time (days) (X1), inoculum size (mL/50 mL medium) (X2) and yeast extract (g/L) (X3) in addition to the predicted uricase production and the residuals. Each of the significant variables was taken at a central coded value of zero and evaluated at five coded levels “−1.68, −1, 0, +1, +1.68”. The response value (Y) in each experiment was uricase production by Aspergillus welwitschiae. Aspergillus welwitschiae uricase activties obtained by the experiments were ranged from 34.56 to 60.03 U/mL. The highest level of uricase production was obtained in run no. 2 with value 60.03 U/mL where the incubation time was 5 days, inoculum size was 0.08 (v/v) and yeast extract concentration was 2 g/L.

Table 4.

Central composite design representing uricase production by Aspergillus welwitschiae as affected by incubation time (days) (X1), inoculum size (mL/50 mL medium) (X2) and yeast extract (g/L) (X3) with actual and coded factor levels.

Std Run Type Variables Uricase activity (U/mL) Residuals
X1 X2 X3 Experimental Predicted
8 1 Factorial 1 1 1 36.28 39.61 −3.33
15 2 Center 0 0 0 60.03 58.08 1.95
5 3 Factorial −1 −1 1 38.19 38.41 −0.22
14 4 Axial 0 0 1.68 34.56 32.82 1.74
17 5 Center 0 0 0 55.47 58.08 −2.61
12 6 Axial 0 1.68 0 42.33 40.29 2.04
13 7 Axial 0 0 −1.68 40.02 40.82 −0.80
18 8 Center 0 0 0 57.29 58.08 −0.79
20 9 Center 0 0 0 58.2 58.08 0.12
11 10 Axial 0 −1.68 0 35.88 36.98 −1.10
16 11 Center 0 0 0 59.11 58.08 1.03
7 12 Factorial −1 1 1 36.95 36.67 0.28
9 13 Axial −1.68 0 0 44.74 46.40 −1.66
10 14 Axial 1.68 0 0 59.01 56.41 2.60
3 15 Factorial −1 1 −1 41.41 41.89 −0.48
4 16 Factorial 1 1 −1 50.65 51.09 −0.44
1 17 Factorial −1 −1 −1 39.11 36.44 2.67
19 18 Center 0 0 0 58.21 58.08 0.13
2 19 Factorial 1 −1 −1 44.46 45.41 −0.95
6 20 Factorial 1 −1 1 40.93 41.12 −0.19
Variable Code Coded and actual levels
−1.68 −1 0 1 1.68
Incubation time (days) X1 3.32 4 5 6 6.68
Inoculum size (mL/50 mL medium) X2 2.32 3 4 5 5.68
Yeast extract (g/L) X3 1.16 1.5 2 2.5 2.84

The CCD experimental data obtained from the 20 experiments were submitted to statistical analysis using design expert 7 software to determine the relationship between variables with the most significant positive effects and uricase production and the results are shown in Tables 57. The model F-value of 35.92 implies the model is significant. Our model has R2 = 0.9700 that mean 97% of the variability in uricase production by Aspergillus welwitschiae could be explained by the independent variables used and only 3% of the variability are not explained by the independent variables. This means that regression model provides an excellent explanation of the relationship between the independent variables and uricase production. In addition to the Adjusted R2 of 0.9430 was very high to prove the accuracy of the model to calculate the predicted uricase production. Also, the adjusted R2 shows a high correlation between the observed and the fitted values of uricase production. The value of C.V. (4.82%) indicates greatest accuracy of the experiment. In addition, PRESS value is 318.46 and the standard deviation and mean values are 2.25 and 46.64; respectively (Table 5).

Table 5.

ANOVA for CCD results of uricase production by Aspergillus welwitschiae.

Source Sum of Squares df Mean Square F-value P-value Prob >F
Model 1633.99 9 181.55 35.92 <0.0001
X1 - (incubation time) 121.05 1 121.05 23.95 0.0006
X2 - (inoculum size) 13.24 1 13.24 2.62 0.1366
X3 - (yeast extract) 77.16 1 77.16 15.27 0.0029
X1 X2 0.03 1 0.03 0.01 0.9413
X1 X3 19.59 1 19.59 3.88 0.0773
X2 X3 25.85 1 25.85 5.11 0.0473
X12 80.21 1 80.21 15.87 0.0026
X22 680.98 1 680.98 134.72 <0.0001
X32 814.05 1 814.05 161.05 <0.0001
Residual 50.55 10 5.05
Lack of Fit 38.22 5 7.64 3.10 0.1199
Pure Error 12.33 5 2.47
Cor Total 1684.53 19
PRESS 318.46 Adeq Precision 15.8864
Std. Dev. 2.25 R 2 0.9700
C.V.% 4.82 Pred R 2 0.8110
Mean 46.64 Adj R 2 0.9430

Table 7.

Fit summary for experimental results of CCD for optimization of uricase production by Aspergillus welwitschiae.

Model Summary Statistics
Source SD R2 Adjusted R2 Predicted R2 PRESS
Linear 9.60 0.1255 −0.0384 −0.2648 2130.67
2FI 10.48 0.1525 −0.2386 −1.1963 3699.77
Quadratic 2.25 0.9700 0.9430 0.8110 318.46
Lack of Fit Tests
Source SS Df MS F- value P- value
Linear 1460.75 11 132.80 53.87 0.0002
2FI 1415.28 8 176.91 71.76 <0.0001
Quadratic 38.22 5 7.64 3.10 0.1199
Pure Error 12.33 5 2.47
Sequential Model Sum of Squares
Linear vs Mean 211.46 3 70.49 0.77 0.5298
2FI vs Linear 45.47 3 15.16 0.14 0.9355
Quadratic vs 2FI 1377.06 3 459.02 90.81 <0.0001
Residual 14.53 6 2.42

“*Significant values, df: degree of freedom, PRESS: sum of squares of prediction error, 2FI: two factors interaction, SD: Standard deviation, SS: Sum of Squares, MS: Mean Square”.

The significance of each variable for uricase production was determined by P-value as listed in Table 5. It can be noted from the degree of significance that the linear coefficients of incubation time (X1) and yeast extract (X3) are significant. Also, the interaction between X2X3 and quadratic effects of the three variables are significant. On the other hand, among the model terms, the linear coefficients of inoculums size (X2), the interaction between incubation time (X1), inoculums size (X2) and the interaction between X1 X3 are not significant and not contribute to uricase production by Aspergillus welwitschiae. Furthermore, the quadratic effects of inoculums size and yeast extract were determined to have very significant effects on the production of uricase by Aspergillus welwitschiae with P-value < 0.0001.

Table 6 shows regression coefficients of the second order polynomial model for optimization of uricase production by Aspergillus welwitschiae and the equation of regression can be obtained in coded terms:

Uricaseactivity=+58.08+2.98X1+0.98X22.38X3+0.06X1X21.57X1X31.80X2X32.36X126.87X227.52X32 2

where X1 is incubation time, X2 is inoculums size and X3 is yeast extract concentration.

Table 6.

Regression coefficients of CCD results of optimization of uricase production by Aspergillus welwitschiae.

Factor Coefficient estimate Standard error 95% CI Low 95% CI High
Intercept 58.08 0.92 56.04 60.12
X1 - (incubation time) 2.98 0.61 1.62 4.33
X2 - (inoculum size) 0.98 0.61 −0.37 2.34
X3 - (yeast extract) −2.38 0.61 −3.73 −1.02
X1 X2 0.06 0.79 −1.71 1.83
X1 X3 −1.57 0.79 −3.34 0.21
X2 X3 −1.80 0.79 −3.57 −0.03
X12 −2.36 0.59 −3.68 −1.04
X22 −6.87 0.59 −8.19 −5.55
X32 −7.52 0.59 −8.84 −6.20

The fit summary results are shown in Table 7, as the model summary statistics used to select the model which has higher adjusted and predicted R2 and lower standrd deviation. Table 7 shows that, the quadratic model is a high-significant and the proper model adequate for the CCD for Aspergillus welwitschiae uricase production with very low P-value (<0.0001) and the model also showed high lack of fit F-value = 3.10 (statistically insignificant lack of fit, P-value = 0.1199). The quadratic model shows the highest adjusted R2 (00.9430) and predicted R2 (0.8110). The quadratic model also shows the smallest standard deviation of 2.25.

Contour and three dimensional (3D) plots

The 3D and Contour plots provide a way to visualize the relationship between the uricase activity and the interactions between the tested variables and to determine the optimal conditions for production of uricase. Three-dimensional plots were created for pairs of the three significant variables by plotting uricase activity against two variables and keeping the third variable at its zero level.

Figure 5A shows the effects of incubation time and inoculums size on uricase production by Aspergillus welwitschiae, while the yeast extract concentration was kept at its zero level (2 g/L). Lower and higher levels of inoculums size cause relatively low production of uricase, the central point of inoculums size (4 mL/50 mL of the production medium) support the maximum uricase production. On the other hand, uricase production increases gradually with increasing incubation time. The highest activity was obtained after 5 days of incubation. By solving the Eq. (2) and analyzing Fig. 5A, the maximum predicted uricase activity of 59.03 U/mL was attained at the optimal predicted levels of incubation time (5.64 days incubation) and inoculum size (4.14 mL/50 mL of the production medium) at yeast extract concentration of 2 g/L.

Figure 5.

Figure 5

3D response surface and contour plots of the effects of incubation time (X1), inocluum size (X2) and yeast extract concentration (X3) and their mutual effect on the uricase activity.

Our results show that Aspergillus welwitschiae uricase activity was found to be 60.03 U/mL at inoculum size of 4 mL/50 mL of the production medium, but Hatijah and Ruhayu34 used 10 mL inoculum to produce uricase from Aspergillus flavus in 90 mL of medium. Nanda et al.16 used 100 μL inoculum of Gliocladium virde to produce uricase in 50 mL of production medium. The effect of inoculum size on the enzyme production is depending on the conditions of culture fermentation such as; nature of the used microbe, incubation time, and the characteristics of used substrate. Also, the fungal sporulation and its metabolic activities are affected by inoculums size35. If the inoculum size is low, it may take longer time to multiply the fungal cells and utilize the substrate to produce the desired enzyme. On the other hand, a high inoculum would create a rapid reproduction of fungal biomass. Consequently, the balance between substrate utilization and proliferating biomass would give maximum enzyme activity as demonstrated by Sherief et al.36. Increase in inoculum size resulted in decreasing enzyme yield due to limitation of nutrients as reported by El-Naggar et al.37.

The second significant factor is the incubation time which significantly affects the enzyme production. In our study the optimum incubation time for maximum uricase production by Aspergillus welwitschiae was 5 days. These results are consistent with the results of Kon et al.38 who reported that the maximum uricase produced by Hyphomyces was obtained after 5 days of incubation. On the other hand, Abdel-Fattah and Abo-Hamed39 reported that uricase was produced from Aspergillus flavus, Aspergillus terreus after 4 days of incubation and from Trichoderma sp. after 6 days. In contrast, Nanda et al.16 proved that Gliocladium viride MTCC 3835 was identified to produce highly active uricase (82.1 U/mL) after 7 days of incubation. Our finding is inconsistent with the results of Atalla et al.40 who reported that the incubation for 8 days was required for maximum production of uricase by Gliomastix gueg. Moreover, Nour El-Dein and El- Fallal41 found that uricase was produced by Aspergillus carbonarius, Botrytis fabae, Aspergillus sydowi after 10 days of incubation. The maximum amount of intracellular uricase produced by Mucor hiemalis in a simple medium was achieved in 24 hours19. Jagathy et al.42 reported that the maximum production of uricase (141 U/mL) by Aspergillus niger was obtained at 96 hours of incubation.

Figure 5B presented the effects of incubation time and yeast extract on uricase production while the inoculums size was retained at its zero level (4 mL/50 mL of the production medium). The maximum production of uricase clearly obtained near the central level of yeast extract concentration (2 g/L) while the higher and lower levels of the yeast extract lead to a lower rate of uricase production. On the other hand, uricase production increases gradually with increasing incubation time and the maximum production of uricase was obtained after 5 days of incubation. By solving the Eq. (2) and analyzing Fig. 5B, the maximum predicted uricase activity (59.41 U/mL) was attained at the optimal predicted levels of incubation time (5.68 days of incubation) and yeast extract concentration (1.89 g/L) at inoculum size of 4 mL/50 mL of the production medium.

The fungal enzymes production is very sensitive to nitrogen source and its level in the medium. Generally, the use of organic nitrogen increases uricase production significantly more than inorganic nitrogen. Organic nitrogen may contain most of the amino acids necessary for microbial growth, which can be directly metabolized by cells to promote the production of uricase. Yeast extracts contain different biologically active compounds, including nucleotides and polysaccharides of the cell wall (especially α-mannan and β-glucan) that are useful for enzyme production. It may be acting as medium components that induce uricase production. Yeast extract is considering one of the effective variables on uricase production. Our results have shown that the optimal concentration of yeast extract for uricase production was 2 g/L. Our findings were agreed with the results obtained by Anderson and Vijayakumar43 who used 2 g/L yeast extract for uricase production by Pseudomonas aeruginosa. Abbas44 also reported that the highest value of specific activity of uricase (14.83 U/mg) produced by Asperigillus niger was obtained using 2% of the yeast extract. However, there is disagreement with Nanda et al.16 who proved that the best concentration of the yeast extract was 10.57 g/L for maximum uricase production (82.1 U/mL) by Gliocladium viride MTCC 3835. The optimal yeast extract concentration for maximum uricase production (0.23 U/mL) by Pseudomonas sp. was 0.5%45. Khucharoenphaisan and Sinma46 reported that 1% yeast extract as a nitrogen source increased uricase production by Saccharopolyspora sp. PNR11 up to 216 mU/mL.

Figure 5C shows the interaction between inoculums size and yeast extract concentration while incubation time was kept at its zero level. By increasing the inoculums size to 4 mL/50 mL of the production medium and yeast extract concentration to 2 g/L, the maximum production of uricase was obtained. By solving the Eq. (2) and analyzing Fig. 5C, the maximum predicted uricase activity of 58.31 U/mL was attained at the optimal predicted levels of inoculums size of 4 mL/50 mL of the production medium and yeast extract concentration of 1.91 g/L at incubation time of 5 days.

Finally, the maximum production of uricase by Aspergillus welwitschiae was found to be 60.03 U/mL where uric acid concentration used was 4 g/L, yeast extract 2 g/L and inoculums size 4 mL at the 5th day of incubation at 35 °C in 50 mL production medium. Our results are higher than the results of Nour El-Dein and El-Fallal41 who found that Aspergillus carbonarius produced uricase with activity of 0.16 U/mL/min and Botrytis fabae, Aspergillus sydowi produced 0.13, and 0.093 U/mL; respectively. While Aspergillus terreus, Aspergillus niger and Aspergillus alutaceus produced below 0.06 U/mL in medium consisted of (% w/v): sucrose, 3; KH2PO4 0.1; Mg SO4. 7H2O 0.05; NaNO3 0.2; uric acid 2.0 and pH 7.4. 50 mL of the liquid medium was inoculated with different fungal strains and incubated at 30 °C or 25 °C for ten days. Yazdi et al.19 found that Mucor hiemalis produced 1.25 U/mL, where uric acid concentration was 7.0 g; the optimum temperature and pH were 30 °C and 6; respectively in 50 mL medium/250 mL conical flask. On the other hand, Nanda et al.16 proved that Gliocladium viride MTCC 3835 was identified to produce highly active uricase (82.1 U/mL) using the optimal concentrations of variables which were yeast extract 10.57 g/L, peptone 12.71 g/L, uric acid 2 g/L, CuSO4 0.0762 g/L and pH 7.5. The inoculated medium was incubated for 7 days at 30 °C in 50 mL production medium.

Model verification

For determination the model accuracy and for verification of the results, an experiment was performed under the optimal conditions obtained from CCD. The experimental uricase activity was 60.03 U/mL which was close to the predicted value of 58.08 U/mL. This revealed a high degree of precision (96.75%).

Materials and Methods

Microorganism and culture maintenance

Aspergillus sp. strain 1–4 that used in this study was newly isolated by the fourth author from soil sample collected from Egypt and cultured on Petri plates containing potato dextrose agar (PDA) medium that composed of potato infusion (infusion from 200 g potatoes), 20 g dextrose, and 15 g agar. After the incubation at 30 °C for 5 days, the plates were maintained at 4 °C for further use.

Extracellular uricase production potential of Aspergillus sp. strain 1–4

The fungal strain was examined for its potential to produce uricase by agar plate assay method on the solidified medium which contains uric acid as an inducing agent. Uric acid screening medium was prepared using the following components (g/L): uric acid 3, sucrose 20, magnesium sulphate heptahydrate 0.5, sodium chloride 0.5, di-potassium hydrogen phosphate 1, ferrous sulphate 0.01 and agar 1539. The pH was adjusted to 6.8 and the inoculated plates were incubated for 5–7 days at 30 °C. Clear zone formed around the fungal colony indicate a positive result for production of uricase. The ability of Aspergillus sp. strain 1–4 to produce uricase was then confirmed under submerged fermentation.

Inoculum preparation and submerged-fermentation

Fifty mL of liquid uric acid production medium of the following composition (g/L): sucrose 20, uric acid 3, NaCl 0.5, K2HPO4 1, MgSO4.7 H2O 0.5, Fe2SO4 0.01, distilled water added up to 1 L, pH adjusted to 6.8, in 250 mL Erlenmeyer flask was inoculated by five discs from five days old stock culture of Aspergillus sp. strain 1–4. The inoculated flask was incubated at 30 °C for 48–72 h, and was used as inoculum for subsequent experiments. The production medium was inoculated with the prepared inoculum and incubated at specified temperature (25–35 °C). After the specified incubation time for each set of experimental trials, the mycelia of the strain 1–4 were collected by centrifugation at 5000 × g for 15 min and the cell free supernatant was used as a crude enzyme preparation for further determinations of the enzymatic activity.

Uricase assay

According to Adamek et al.9 procedures, uricase activity was assayed. Assay mixture containing two mL of buffer solution containing uric acid (0.06 mM uric acid in 0.2 M sodium borate buffer, pH 8.5), 0.8 mL of distilled water and 0.1 mL of crude enzyme preparation was incubated at 37 °C in water bath for 30 min. After 30 min of incubation, 0.2 mL of 0.1 M potassium cyanide solution was added to the mixture to stop the enzyme reaction. The blank was prepared by adding potassium cyanide solution before adding the uricase. The absorbance was measured spectrophotometrically against the blank at 293 nm. The difference between the absorbance of the sample and the blank is directly proportional to the decrease in uric acid concentration throughout uricase reaction. One unit of uricase is defined as the amount of the uricase that produces 1 µmol of hydrogen peroxide per minute under the assay conditions.

Scanning electron microscopy

Scanning electron microscopy is a useful tool for studying fungi. It allows the study of several aspects of morphology47. The gold-coated dehydrated fungal growth specimen was examined at different magnifications using “Analytical Scanning Electron Microscope (JSM-6510 LV) at Electron Microscope unit, Mansoura University, Mansoura, Egypt”.

Molecular identification of Aspergillus welwitschiae and phylogenetic analysis

The preparation of genomic DNA of Aspergillus sp. strain 1–4 was conducted in accordance with the methods described by Sambrook et al.48. DNA extraction, polymerase chain reaction (PCR) and 18S rRNA sequencing were performed by Macrogen Korea Company Gasan-dong, Geumchen-gu, Seoul, Korea (http://www.macrogen.com). The amplification of 18S rRNA gene from Aspergillus sp. strain 1–4 was carried out via PCR. Primers used were reverse primer ITS4 “5′-TCCTCCGCTTATTGATATGC-3′” and forward primer ITS1 “3′-TCCGTAGGTGAACCTGCGG-5′”. The amplification was carried out in 100 μl contained: “1 μl DNA, 10 μl of 250 mM dNTP’s; 10 μl PCR buffer, 3.5 μl 25 mM MgCl2 and 0.5 μl Taq polymerase, 4 μl of 10 pmol (each) forward and reverse primer and water was added up to 100 μl”. Components of the PCR reaction were mixed thoroughly. DNA amplification was carried out in the thermal cycles using the following PCR programme: 10 min denaturation at 95 °C, then 30 sec of 35 amplification cycles at 95 °C, annealing of 1 min at 55 °C, extension of 1 min at 72 °C, and 15 min final extension at 72 °C, number of cycles equal 35. The PCR reaction mixture was purified using purification Kit of Thermo (GeneJET™ PCR, K0701) K0701.

Phylogenetic analysis

The obtained sequences of 18S rRNA gene for Aspergillus sp. strain 1–4 was analyzed using basic local alignment search tool (BLAST)26 (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome) at NCBI database and the obtained sequence was compared with the 18S rRNA related sequences of representative members of fungi retrieved from the Gen Bank, DDBJ, PDB and EMBL databases. The phylogenetic tree was constructed via the neighbor-joining algorithm27 using the software package MEGA4 version 2.149.

Screening of various process factors influences uricase production by Plackett–Burman design

Plackett-Burman technique was used to screen the fermentation medium components and the environmental conditions to identify the foremost important variables that had a significant impact on the production of uricase. The statistical experimental design of Plackett and Burman50 is very useful in identifying the most significant variables with regard to their main effects51. Plackett–Burman statistical experimental design does not describe the interaction between variables and is used only to screen and evaluate the important variables that affect the response52. A number of tools may be used to help assessing the significance of each process factor. This includes normal plots, P-values, and Pareto charts.

Based on the Plackett-Burman factorial design, the nutritional and environmental requirements of Aspergillus sp. strain 1–4 for uricase production were examined in two levels which were low level (−1) and high level (+1). In our study, fifteen independent variables were examined for selection of significant variables for uricase production; these variables included different energy sources, nitrogen sources, carbon sources, metals and physical variables. In addition, four unassigned dummy variables (D1–D4) were used for estimation of the experimental errors in data analysis.

Plackett–Burman experimental design is based on the equation of the first order polynomial model:

Y=β0+βiXi 3

where, Y is the activity of uricase; β0 is the intercept of the model; βi is the linear coefficient and Xi is the independent factors levels. All experiments were performed in duplicate and the responses were considered to be the average uricase activity.

Optimization of uricase production by using central composite design (CCD)

Based on the results of Plackett-Burman experiment, the three variables with most significant positive effect on uricase production by Aspergillus sp. strain 1–4 and had the highest percentage of contribution were further optimized using CCD. These variables were coded as X1, X2 and X3 and examined in 5 levels which were −1.68, −1, 0, +1, +1.68. According to the CCD design, combinations of the three independent variables were conducted in twenty experiments and the results were fitted to the following equation of second order polynomial model:

Y=β0+iβiXi+iiβiiXi2+ijβijXiXj 4

Y is the predicted uricase activity, βi is the linear coefficient, β0 is the regression coefficients, Xi is the coded levels of the independent variables, βij is the interaction coefficients and βii is the quadratic coefficients.

Statistical analysis

The obtained results were subjected to multiple linear regression analysis using “Design Expert software version 7 (Stat-Ease Inc., USA) for Windows. The statistical software package, STATISTICA software (Version 8.0, StatSoft Inc., Tulsa, USA) was used to plot the three-dimensional surface plots”.

Conclusion

Different fifteen nutritional and environmental variables were screened for their significances on uricase production by Aspergillus welwitschiae using Plackett-Burman statistical design. Incubation time, inoculum size and yeast extract concentration identified by Plackett-Burman design as the most significant variables affecting positively uricase production by Aspergillus welwitschiae and were further optimized using central composite design. By using CCD, the optimal levels for these variables were: 5 days of incubation time, 2 g/L yeast extract and inoculums size 4 mL for maximum production of uricase by Aspergillus welwitschiae (60.03 U/mL), when 4 g/L uric acid, 50 mL production medium/250 mL conical flask were used and incubated at 35 °C. Uricase production in the optimized medium was increased up to 3.02- times compared to the initial medium of production. Our future studies will be will focus on semi-industrial production, purification and characterization of uricase along with its pharmacological characteristics, which will be very helpful when designing a novel strategy for the treatment of certain diseases such as chronic gout, tumor lysis hyperuricemia and organ transplants hyperuricemia.

Supplementary information

Author Contributions

NEE proposed the research concept, designed the experiments, providing some necessary tools for experiments, experimental instructions, analyzed and interpreted the results, contributed substantially to the writing of the manuscript, reviewing and revising of the manuscript and final approval of the manuscript. SAH participated in the manuscript revision. EME performed the experiments, collected the data and contributed substantially to the writing of the manuscript. EAM providing the fungal strain used in this study, contributed to the manuscript writing. AAS participated in the manuscript revision. All authors read and approved the final manuscript.

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary information accompanies this paper at 10.1038/s41598-019-49201-1.

References

  • 1.Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol. 2010;6(1):30–8. doi: 10.1038/nrrheum.2009.236. [DOI] [PubMed] [Google Scholar]
  • 2.Nakagawa T, et al. Uric acid-a uremic toxin. Blood Purif. 2006;24:67–70. doi: 10.1159/000089440. [DOI] [PubMed] [Google Scholar]
  • 3.Tausche AK, et al. Gout-current diagnosis and treatment. Dtsch Arztebl Int. 2009;106:549–55. doi: 10.3238/arztebl.2009.0549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Capasso G, Jaeger P, Robertson WG, Unwin RJ. Uric acid and the kidney: urate transport, stone disease and progressive renal failure. Curr Pharm Des. 2005;11:4153–4159. doi: 10.2174/138161205774913219. [DOI] [PubMed] [Google Scholar]
  • 5.Masseoud D, Rott K, Liu-Bryan R, Agudelo C. Overview of hyperuricaemia and gout. Curr Pharm Des. 2005;11:4117–4124. doi: 10.2174/138161205774913318. [DOI] [PubMed] [Google Scholar]
  • 6.Larsen G, Loghman-Adham M. Acute renal failure with hyperuricemia as initial presentation of leukemia in children. J Pediatr Hematol Oncol. 1996;18:191–194. doi: 10.1097/00043426-199605000-00020. [DOI] [PubMed] [Google Scholar]
  • 7.Kelly, W. N. & Pelella, T. D. Gout and other disorders of purine metabolism. In: Braunwald E. et al. editors. Harrison’s principles of internal medicine. New York: McGraw Hill. 1623–1632 (1987).
  • 8.Brogard JM, Coumaros D, Frankckhauser J, Stahl A, Stahl J. Enzymatic uricolysis: a study of the effect of a fungal urate oxidase. Europeenne D Etudes Cliniques Et Biologique. 1972;17:890–895. [PubMed] [Google Scholar]
  • 9.Adamek V, Kralova B, Suchova M, Valentova O, Demnerova K. Purification of microbial uricase. J Chromatogr. 1989;497:268–275. doi: 10.1016/0378-4347(89)80028-3. [DOI] [PubMed] [Google Scholar]
  • 10.Bomalaski JS, Clark MA. Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase. Curr Rheumatol Rep. 2004;6:240–247. doi: 10.1007/s11926-004-0075-3. [DOI] [PubMed] [Google Scholar]
  • 11.Ganson NJ, Kelly SJ, Scarlett E, Sundy JS, Hershfield MS. Control of hyperuricemia in subjects with refractory gout and induction of antibody against poly (ethylene glycol) (peg), in a phase I trial of subcutaneous pegylated urate oxidase. Arthritis Res Ther. 2006;8(1):R12. doi: 10.1186/ar1861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Colloc’h N, et al. Crystal structures of the protein drug urate oxidase-inhibitor complex at 2.05 A° resolution. BMC Struct Biol. 1997;4:947–952. doi: 10.1038/nsb1197-947. [DOI] [PubMed] [Google Scholar]
  • 13.Arslan F. An amperometric biosensor for uric acid determination prepared from uricase immobilized in polyaniline-polypyrrole film. Sens. 2008;8:5492–500. doi: 10.3390/s8095492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Cannella AC, Mikuls TR. Understanding treatments for gout. Am J Manag Care. 2005;11:451–458. [PubMed] [Google Scholar]
  • 15.Nakagawa S, Oda H, Anazawa H. High cell density cultivation and high recombinant protein production of Escherichia coli strain expression uricase. Biosci Biotechnol Biochem. 1995;59:2263–2267. doi: 10.1271/bbb.59.2263. [DOI] [PubMed] [Google Scholar]
  • 16.Nanda P, Babu PEJ, Fernandes J, Hazarika P, Dhabre RR. Studies on production, optimization and purification of uricase from Gliocladium viride. Res Biotechnol. 2012;3(4):35–46. [Google Scholar]
  • 17.Poovizh T, Gajalakshmi P, Jayalakshmi S. Production of uricase Atherapeutic enzyme from Pseudomonas putida isolated from poultry waste. Int J adv Res. 2014;2(1):34–40. [Google Scholar]
  • 18.Ishikawa J, et al. The complete genomic sequence of Nocardia farcinica IFM 10152. Proc Natl Acad Sci USA. 2004;101:14925–14930. doi: 10.1073/pnas.0406410101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yazdi MT, et al. Mucor hiemalis: a new source for uricase production. World J Microbiol Biotechnol. 2006;22:325–330. doi: 10.1007/s11274-005-9030-3. [DOI] [Google Scholar]
  • 20.Wang Z, et al. Uricase production by a recombinant Hansenula polymorpha strain harboring Candida utilis uricase gene. Appl Microbiol Biotechnol. 2008;79(4):545–54. doi: 10.1007/s00253-008-1466-6. [DOI] [PubMed] [Google Scholar]
  • 21.El-Naggar NE, Hamouda RA. Antimicrobial potentialities of Streptomyces lienomycini NEAE-31 against human pathogen multidrug-resistant Pseudomonas aeruginosa. Int J Pharmacol. 2016;12:769–788. doi: 10.3923/ijp.2016.769.788. [DOI] [Google Scholar]
  • 22.El-Naggar NE. Extracellular production of the oncolytic enzyme, L-asparaginase, by newly isolated Streptomyces sp. strain NEAE-95 as potential microbial cell factories: Optimization of culture conditions using response surface methodology. Curr Pharm Biotechnol. 2015;16(2):162–178. doi: 10.2174/1389201015666141113123910. [DOI] [PubMed] [Google Scholar]
  • 23.El-Naggar Noura El-Ahmady. Isolation, Screening and Identification of Actinobacteria with Uricase Activity: Statistical Optimization of Fermentation Conditions for Improved Production of Uricase by Streptomyces rochei NEAE-25. International Journal of Pharmacology. 2015;11(7):644–658. doi: 10.3923/ijp.2015.644.658. [DOI] [Google Scholar]
  • 24.El-Naggar, N. E., Moawad, H., El-Shweihy, N. M. & El-Ewasy, S. M. Optimization of culture conditions for production of the anti-leukemic glutaminase free L-asparaginase by newly isolated Streptomyces olivaceus NEAE-119 using response surface methodology. BioMed Res Int (2015c). [DOI] [PMC free article] [PubMed]
  • 25.Dwivedi H, Agrawal K, Saraf SA. Evaluation of factors affecting uricase production by the screened wild/natural microbes. E-J Chem. 2012;9(4):2287–2296. doi: 10.1155/2012/976242. [DOI] [Google Scholar]
  • 26.Altschul SF, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389–3444. doi: 10.1093/nar/25.17.3389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406–425. doi: 10.1093/oxfordjournals.molbev.a040454. [DOI] [PubMed] [Google Scholar]
  • 28.Strobel, R. J. & Sullivan, G. R. Experimental design for improvement of fermentation. In: Demain, A. L. & Davies, J. E. (eds) Manual of industrial microbiology and biotechnology, 2nd edn. ASM press,Washington, DC, 80–93 (1999).
  • 29.Niladevi KN, Sukumaran RK, Jacob N, Anisha GS, Prema P. Optimization of laccase production from a novel strain Streptomyces psammoticus using response surface methodology. Microbiol Res. 2009;3(1):105–113. doi: 10.1016/j.micres.2006.10.006. [DOI] [PubMed] [Google Scholar]
  • 30.Levine Ross. Handbook of Economic Growth. 2005. Chapter 12 Finance and Growth: Theory and Evidence; pp. 865–934. [Google Scholar]
  • 31.Chaiyaso T, et al. Optimization of cellulase-free xylanase production by thermophilic Streptomyces thermovulgaris TISTR1948 through Plackett-Burman and response surface methodological approaches. Biosci Biotechnol Biochem. 2011;75:531–537. doi: 10.1271/bbb.100756. [DOI] [PubMed] [Google Scholar]
  • 32.Stowe RA, Mayer RP. Efficient screening of process variables. Ind Eng Chem. 1966;58:36–40. doi: 10.1021/ie50674a007. [DOI] [Google Scholar]
  • 33.Chen XC, et al. Medium optimization for the production of cyclic adenosine 3′,5′-monophosphate by Microbacterium sp. no. 205 using response surface methodology. Biores Technol. 2009;100:919–924. doi: 10.1016/j.biortech.2008.07.062. [DOI] [PubMed] [Google Scholar]
  • 34.Hatijah MS, Ruhayu WRW. Preliminary study on factors that enhanced the production of uricase by Aspergillus flavus. Int J Biosci Biochem Bioinf. 2013;3(5):513–515. [Google Scholar]
  • 35.Domingues FS, Lackner P, Sippl MJ. Structure-based evaluation of sequence comparison and fold recognition alignment accuracy. J Mol Biol. 2000;297:1003–1013. doi: 10.1006/jmbi.2000.3615. [DOI] [PubMed] [Google Scholar]
  • 36.Sherief AA, El-Naggar NE, Hamza SS. Bioprocessing of lignocellulosic biomass for production of renewable bioethanol using thermotolerant Aspergillus fumigates under solid state fermentation conditions. Biotechnol. 2010;9(4):513–522. doi: 10.3923/biotech.2010.513.522. [DOI] [Google Scholar]
  • 37.El-Naggar, N. E., Sherief A. A & Hamza, S. S. Bioconversion process of rice straw by thermotolerant cellulolytic Streptomyces viridiochromogenes under solid-state fermentation conditions for bioethanol production. Afr J Biotechnol10, 1224412251.
  • 38.Kon Y, Dobashi Y, Katsura H. The characteristics of uricase production by a Hyphomycetes isolated from the excrements of Cettia diphone cantans. II. The effectiveness of purines and pyrimidines as substrates. Yakugaku Zasshi. 1976;96(4):484–489. doi: 10.1248/yakushi1947.96.4_484. [DOI] [PubMed] [Google Scholar]
  • 39.Abdel-Fattah MG, Abo-Hamed NA. Bioconversion of poultry waste I – Factors influencing the assay and productivity of crude uricase by three uricolytic filamentous fungi. Acta Microbio et Immunologica Hungarica. 2002;49(4):445–454. doi: 10.1556/AMicr.49.2002.4.3. [DOI] [PubMed] [Google Scholar]
  • 40.Atalla MM, Farag MM, Eman RH, Abd-El-Lataif MS, Nehad EA. Optimum conditions for uricase enzyme production by Gliomastix gueg. Malays J Microbiol. 2009;5:45–50. [Google Scholar]
  • 41.Nour El-Dein MM, El-Fallal A. Screening of some fungi for uricolytic activity. Qatar Univ Sci J. 1996;16(1):71–76. [Google Scholar]
  • 42.Jagathy K, Ronald J, Pushparaj A. Optimization and production of uricase enzyme from Aspergillus niger isolated from mangrove sediment. Int J Adv Multidiscip Res. 2016;3(7):1–11. [Google Scholar]
  • 43.Anderson A, Vijayakumar S. Isolation and optimization of Pseudomonas aeruginosa for uricase production. Int J Pharm Bio Sci. 2012;3(11):143–150. [Google Scholar]
  • 44.Abbas AA. Extraction, optimization of uricase from Aspergillus niger. Int. J Adv Res. 2016;4(3):1865–1872. [Google Scholar]
  • 45.Ghasemian A, Moradpour Z, Baniasad M, Ghasemi Y. Isolation, molecular identification and characterization of the culture conditions for extracellular uricase production by a new strain of Pseudomonas sp. J Pure. Appl Microbiol. 2015;9(4):2813–2821. [Google Scholar]
  • 46.Khucharoenphaisan K, Sinma K. Production and partial characterization of uric acid degrading enzyme from new source Saccharopolyspora sp. PNR11. Pakistan J Biol Sci. 2011;14:226–231. doi: 10.3923/pjbs.2011.226.231. [DOI] [PubMed] [Google Scholar]
  • 47.Ito Y, Nozawa Y, Setoguti T. Examination of several selected fungi by scanning electron microscope. Mycopathologia. 1970;41:299–305. doi: 10.1007/BF02051109. [DOI] [PubMed] [Google Scholar]
  • 48.Sambrook, J., Fritsch, E. F. & Maniaties, T. Molecular cloning: A laboratory Manual 2nd Cold. Spring, Harbor Laboratory press, Cold Spring Harbor, New York, USA (1989).
  • 49.Tamura K, Dudley J, Nei M, Kumar S. Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–1599. doi: 10.1093/molbev/msm092. [DOI] [PubMed] [Google Scholar]
  • 50.Plackett RL, Burman JP. The design of optimum multifactorial experiments. Biometrika. 1946;33:305–325. doi: 10.1093/biomet/33.4.305. [DOI] [Google Scholar]
  • 51.Krishnan S, Prapulla SG, Rajalakshmi D, Misra MC, Karanth NG. Screening and selection of media components for lactic acid production using Plackett-Burman design. Bioprocess Eng. 1998;19:61–65. doi: 10.1007/PL00009003. [DOI] [Google Scholar]
  • 52.Salihua, A., Alama, M. Z., AbdulKarima, M. I. & Salleha, H. M. Optimization of lipase production by Candida cylindracea in palm oil mill effluent based medium using statistical experimental design. 69, 66–73 (2011).

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES